PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of pubhealthrepLink to Publisher's site
 
Public Health Rep. 1998 June; 113(Suppl 1): 19–30.
PMCID: PMC1307724

Outreach-based HIV prevention for injecting drug users: a review of published outcome data.

Abstract

OBJECTIVE: Over the past decade, a body of observational research has accrued about the effects of outreach-based human immunodeficiency virus (HIV) interventions for drug users. The authors reviewed the findings related to postintervention behavior changes and integrated findings across studies to provide the best estimate of program impact. METHODS: The authors conducted a computerized literature search to locate published accounts of HIV intervention effects on drug users. Thirty-six publications covered outreach-based HIV risk reduction interventions for out-of-treatment injecting drug users (IDUs) and reported intervention effects on HIV-related behaviors or HIV seroincidence. Two-thirds of the publications reported that participation in street-based outreach interventions was followed with office-based HIV testing and counseling. The authors described the theoretical underpinnings of outreach intervention components, the content of the interventions, and the outcome measures that investigators used most frequently. The authors also described and critiqued the evaluation study designs that were in place. Because most of the evaluations were based on pretest and posttest measures of behavior rather than on controlled studies, results were examined with respect to accepted criteria for attributing intervention causality, that is, the plausibility of cause and effect, correct temporal sequence, consistency of findings across reports, strength of associations observed, specifically of associations, and dose-response relationships between interventions and observed outcomes. RESULTS: The majority of the published evaluations showed that IDUs in a variety of places and time periods changed their baseline drug-related and sex-related risk behaviors following their participation in a outreach-based HIV risk reduction intervention. More specifically, the publications indicated that IDUs regularly reported significant follow-up reductions in drug injection, multiperson reuse of syringes and needles, multiperson reuse of other injection equipment (cookers, cotton, rinse water), and crack use. The studies also showed significant intervention effects in promoting entry into drug treatment and increasing needle disinfection. Although drug users also significantly reduced sex-related risks and increased condom use, the majority still practiced unsafe sex. One quasi-experimental study found that reductions in injection risk led to significantly reduced HIV seroincidence among outreach participants. Few investigators looked at dosage effects, but two reports suggested that the longer the exposure to outreach-based interventions, the greater the reductions in drug injection frequency. CONCLUSIONS: Accumulated evidence from observational and quasi-experimental studies strongly indicate that outreach-based interventions have been effective in reaching out-of-treatment IDUs, providing the means for behavior changes and inducing behavior change in the desired direction. The findings provide sound evidence that participation in outreach-based prevention programs can lead to lower HIV incidence rates among program participants.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (5.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Des Jarlais DC, Hagan H, Friedman SR, Friedmann P, Goldberg D, Frischer M, Green S, Tunving K, Ljungberg B, Wodak A, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995 Oct 18;274(15):1226–1231. [PubMed]
  • Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q. 1984 Spring;11(1):1–47. [PubMed]
  • Neaigus A, Sufian M, Friedman SR, Goldsmith DS, Stepherson B, Mota P, Pascal J, Des Jarlais DC. Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Educ Prev. 1990 Winter;2(4):253–271. [PubMed]
  • Sufian M, Friedman SR, Curtis R, Neaigus A, Stepherson B. Organizing as a new approach to AIDS risk reduction for intravenous drug users. J Addict Dis. 1991;10(4):89–98. [PubMed]
  • Friedman SR, Neaigus A, Des Jarlais DC, Sotheran JL, Woods J, Sufian M, Stepherson B, Sterk C. Social intervention against AIDS among injecting drug users. Br J Addict. 1992 Mar;87(3):393–404. [PubMed]
  • Rietmeijer CA, Kane MS, Simons PZ, Corby NH, Wolitski RJ, Higgins DL, Judson FN, Cohn DL. Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted, community-level HIV prevention program. AIDS. 1996 Mar;10(3):291–298. [PubMed]
  • Colón HM, Sahai H, Robles RR, Matos TD. Effects of a community outreach program in HIV risk behaviors among injection drug users in San Juan, Puerto Rico: an analysis of trends. AIDS Educ Prev. 1995 Jun;7(3):195–209. [PubMed]
  • Colón HM, Robles RR, Freeman D, Matos T. Effects of a HIV risk reduction education program among injection drug users in Puerto Rico. P R Health Sci J. 1993 Apr;12(1):27–34. [PubMed]
  • Booth RE, Crowley TJ, Zhang Y. Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users. Drug Alcohol Depend. 1996 Sep;42(1):11–20. [PubMed]
  • Kotranski L, Semaan S, Collier K, Lauby J, Halbert J, Feighan K. Effectiveness of an HIV risk reduction counseling intervention for out-of-treatment drug users. AIDS Educ Prev. 1998 Feb;10(1):19–33. [PubMed]
  • McCoy HV, McCoy CB, Lai S. Effectiveness of HIV interventions among women drug users. Women Health. 1998;27(1-2):49–66. [PubMed]
  • Wiebel WW, Jimenez A, Johnson W, Ouellet L, Jovanovic B, Lampinen T, Murray J, O'Brien MU. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):282–289. [PubMed]
  • Booth R, Koester S, Brewster JT, Weibel WW, Fritz RB. Intravenous drug users and AIDS: risk behaviors. Am J Drug Alcohol Abuse. 1991 Sep;17(3):337–353. [PubMed]
  • Stephens RC, Feucht TE, Roman SW. Effects of an intervention program on AIDS-related drug and needle behavior among intravenous drug users. Am J Public Health. 1991 May;81(5):568–571. [PubMed]
  • Colón HM, Rivera Robles R, Sahai H, Matos T. Changes in HIV risk behaviors among intravenous drug users in San Juan, Puerto Rico. Br J Addict. 1992 Apr;87(4):585–590. [PubMed]
  • Birkel RC, Golaszewski T, Koman JJ, 3rd, Singh BK, Catan V, Souply K. Findings from the Horizontes Acquired Immune Deficiency Syndrome Education project: the impact of indigenous outreach workers as change agents for injection drug users. Health Educ Q. 1993 Winter;20(4):523–538. [PubMed]
  • Bux DA, Iguchi MY, Lidz V, Baxter RC, Platt JJ. Participation in an outreach-based coupon distribution program for free methadone detoxification. Hosp Community Psychiatry. 1993 Nov;44(11):1066–1072. [PubMed]
  • Deren S, Davis WR, Beardsley M, Tortu S, Clatts M. Outcomes of a risk-reduction intervention with high-risk populations: the Harlem AIDS project. AIDS Educ Prev. 1995 Oct;7(5):379–390. [PubMed]
  • Siegal HA, Falck RS, Carlson RG, Wang J. Reducing HIV needle risk behaviors among injection-drug users in the Midwest: an evaluation of the efficacy of standard and enhanced interventions. AIDS Educ Prev. 1995 Aug;7(4):308–319. [PubMed]
  • Robles RR, Matos TD, Colon HM, Marrero CA, Reyes JC. Effects of HIV testing and counseling on reducing HIV risk behavior among two ethnic groups. Drugs Soc (New York) 1996;9(1-2):173–184. [PubMed]
  • Stevens SJ, Estrada AL, Estrada BD. HIV sex and drug risk behavior and behavior change in a national sample of injection drug and crack cocaine using women. Women Health. 1998;27(1-2):25–48. [PubMed]
  • Des Jarlais DC, Friedman SR, Stoneburner RL. HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Rev Infect Dis. 1988 Jan-Feb;10(1):151–158. [PubMed]

Articles from Public Health Reports are provided here courtesy of Association of Schools of Public Health